Categories

When your depression fails to respond to traditional prescription medication, it can feel disheartening. Treatment-resistant depression is an obstacle for many people. Spravato, an FDA-approved esketamine nasal spray, has shown great promise in helping those with treatment-resistant depression get back to desired day-to-day activities. Spravato interacts with the NMDA receptors...

If you are living with depression, you may have become overwhelmed by the process of finding a treatment that works for you. Traditional therapies often come with a long list of unpleasant side effects, require extensive periods of trial-and-error, or are expensive and not covered by insurance.  Spravato is an...

For individuals battling treatment-resistant depression, SPRAVATO® (esketamine) offers a promising path to relief. Unlike traditional antidepressants, which primarily target neurotransmitters such as serotonin, dopamine, and norepinephrine, SPRAVATO® works by affecting NMDA (N-methyl-D-aspartate) receptors in the brain. This unique mechanism of action helps to regulate glutamate, an important neurotransmitter involved in...